腫瘤免疫治療實驗室
TUMOR IMMUNOTHERAPY LAB
Dr. Kuang-Wen Liao
The institute of Molecular Medicine and Bioengineering
College of Biological Science and Technology
National Chiao Tung University
Rm.731 303, Xian-Chi Building, No. 75, Bo’ai St., East Dist., Hsinchu City 300, Taiwan (R.O.C.)
新竹市東區博愛街75號賢齊館7F-731室(老師辦公室), 729(學生研究室), 735(共同實驗室)
News
Paper Acceptance
Jan, 2023
Congratulations! The study "Transdermal nanolipoplex simultaneously inhibits subcutaneous melanoma growth and suppresses systemically metastatic melanoma by activating host immunity" has been accepted by the Journal, Nanomedicine: nanotechnology biology and medicine (see more: PMID: 36400317).
July 09, 2020
Congratulations! The study "A panel of eight microRNAs is a good predictive parameter for triple-negative breast cancer relapse" has been accepted by the Journal, Theranostics, and has been presented on the cover of journal (see more: PMID: 32754277)
July 12, 2020
Congratulations! The novel lipoplex, LPPC, used in targeted gene therapy has been accepted by the Journal of Nanobiotechnology (PMID: 32272948)
恭喜本實驗室廖光文老師成為台灣抗體協會第四屆理事
2022
恭喜廖光文教授榮獲105年度科技部傑出研究獎
July 12, 2016
The paper was accepted by PNAS
Nov 20, 2016
Congratulate to Dr. Lin for publishing the paper on the journal of PNAS, which title is In vivo amelioration of endogenous antitumor autoantibodies via low-dose P4N through the LTA4H/activin A/BAFF pathway.
最後更新於 2020/06/18
Welcome to Join
癌症治療策略
抗體藥物開發
生物資訊平台
保健食品開發
高效率抗體製備平台
相關影音
與兆鴻生技公司合作開發蜆蛋白保健食品
蜆蛋白萃取物
本實驗室目前執行農委會計畫，研究海木耳多醣及蜆蛋白對於預防退化性關節炎之功效評估
